Find, compare & contact
Chondroitin sulfate API Manufacturers & Suppliers

Looking for Chondroitin sulfate API 24967-93-9?

Description:

Here you will find a list of producers, manufacturers and distributors of Chondroitin sulfate. You can filter on certificates such as GMP, FDA, CEP, Written Confirmation and more. Send inquiries for free and get in direct contact with the supplier of your choice.

API | Excipient name:

Chondroitin sulfate 

Synonyms:

Chondroitin sulfate sodium  

Cas Number:

24967-93-9 

DrugBank number:

DB09301 

Chondroitin sulfate is a type of Means for diseases of the bone and muscular system

The pharmaceutical API subcategory known as "Means for diseases of the bone and muscular system" refers to a specialized class of active pharmaceutical ingredients (APIs) designed to target and treat various disorders related to the skeletal and muscular systems. These APIs play a crucial role in the development of medications that alleviate symptoms and improve the quality of life for individuals affected by bone and muscular conditions.

One common group of APIs in this subcategory includes bisphosphonates, which are widely used for the treatment of osteoporosis. These compounds inhibit bone resorption, thereby increasing bone density and reducing the risk of fractures. Bisphosphonates act by targeting specific enzymes involved in bone breakdown, preventing excessive bone loss.

Another significant class of APIs for bone and muscular diseases are muscle relaxants. These compounds help alleviate muscle spasms and stiffness associated with conditions such as muscle strains, sprains, and certain neurological disorders. Muscle relaxants work by interfering with the signals sent between the brain and the muscles, inducing relaxation and reducing pain.

Additionally, APIs like calcitonin analogs are utilized for the management of conditions such as Paget's disease and osteoporosis. Calcitonin analogs function by inhibiting osteoclast activity, reducing bone resorption, and promoting bone formation.

In summary, the subcategory of "Means for diseases of the bone and muscular system" encompasses APIs that target bone metabolism, muscle relaxation, and bone remodeling processes. These pharmaceutical ingredients play a vital role in the development of medications aimed at improving the well-being and mobility of individuals suffering from bone and muscular disorders.

Chondroitin sulfate (Means for diseases of the bone and muscular system), classified under Metabolic Bone Disease Agents

Metabolic Bone Disease Agents are a category of pharmaceutical active pharmaceutical ingredients (APIs) that are specifically designed to treat and manage conditions related to the bones and their metabolism. These agents play a crucial role in the treatment of various metabolic bone diseases, including osteoporosis, Paget's disease, and rickets.

The primary function of Metabolic Bone Disease Agents is to regulate bone remodeling and maintain bone health. They achieve this by targeting specific pathways involved in bone metabolism, such as osteoclast and osteoblast activity, calcium regulation, and vitamin D metabolism.

These APIs are commonly used in the development of medications, including oral tablets, injectables, and topical formulations, for the effective treatment of metabolic bone diseases. They are carefully formulated to optimize their pharmacokinetic and pharmacodynamic properties, ensuring maximum efficacy and minimal side effects.

Metabolic Bone Disease Agents encompass a range of substances, including bisphosphonates, selective estrogen receptor modulators (SERMs), calcitonin, and vitamin D analogs. These APIs act through different mechanisms to address specific aspects of bone health, such as inhibiting bone resorption, promoting bone formation, or regulating calcium levels.

In conclusion, Metabolic Bone Disease Agents are a vital category of pharmaceutical APIs used in the development of medications for the treatment and management of various metabolic bone diseases. These agents target specific pathways involved in bone metabolism to regulate bone remodeling, enhance bone health, and alleviate the symptoms associated with these conditions.

• Sinoway industrial Co.,Ltd from China, product country of origin China
• Kraeber & Co GmbH from Germany, product country of origin Germany
• Shandong Octagon Chemicals Limited from China, product country of origin China
• Tangshan Sanxin Bio from China, product country of origin China
• Maruha Nichiro from Japan, product country of origin Japan
• Sioux Pharm from United States, product country of origin United States
• Syntex from Argentina, product country of origin Argentina
• MEITEK from United States, product country of origin China
• Qingdao WanTuMing from China, product country of origin China
• Jiaxing Hengjie Biopharmaceutical from China, product country of origin China
• Pierre Fabre Medi. from France, product country of origin France
• Jiangyin Tsi Pharma from China, product country of origin China
• Lab. Derivati Organici from Italy, product country of origin Italy
• Solabia from France, product country of origin France
• Beloorbayir Biotech from India, product country of origin India
• Internacional Farma from Argentina, product country of origin Argentina
• Shandong Zhongyuan Greentech from China, product country of origin China
• Yantai Dongcheng Bio. from China, product country of origin China

Let the supplier know whether you are looking for a product with a specific monograph such as EP (Ph. Eur.), USP, JP, BP or another quality. Or, whether you are looking for hydrochloride (HCl), anhydricum, base, micronisatum or a specific purity.

You can use the filters to find high-quality suppliers. For example, you can select GMP, FDA or ISO certified suppliers. Visit our FAQ page or use the chat box in the corner to get more information about Pharmaoffer.